Not exact matches
«When you start to do systematic studies of biological systems and you gather information from different angles — meaning
genomics, proteomics, and
other approaches — and combine this information, you end up being able to do discoveries which would not be possible under each individual set of information,» says Figeys.
And
other options do exist: funding from
other organizations for evolution - related research has increased, especially for the
genomics approaches (large - scale DNA sequencing and bioinformatics) that underpin molecular evolution research.
«We're confident that applying this same
approach to a lot of new data will help us discover additional
genomic variations and identify specific genes that play a role in schizophrenia and
other psychiatric conditions.»
Highlight best practices and lessons learned to enable
others to effectively implement
genomic medicine
approaches
We are currently quantifying the genetic variability of this gene as well as
other closely linked genes using a
genomic approach.
We are investigating these and
other allied questions using evolutionary
genomic approaches, by performing comparative analyses of plant genomes, transcriptomes and proteomes.
This section invites manuscripts describing (a) Linkage, association, substitution or positional mapping and epigenetic studies in any species; (b) Validation studies of candidate genes using genetically - engineered mutant model organisms; (c) Studies focused on epistatis and gene - environment interactions; (d) Analysis of the functional implications of
genomic sequence variation and aim to attach physiological or pharmacogenomic relevance to alterations in genes or proteins; (e) Studies of DNA copy number variants, non-coding RNA, genome deletions, insertions, duplications and
other single nucleotide polymorphisms and their relevance to physiology or pharmacology in humans or model organisms, in vitro or in vivo; and (f) Theoretical
approaches to analysis of sequence variation.
MELGEN will explore emergent new techniques, for example the Sanger Institute (GRL) and ServiceXS will explore new
approaches to
genomic data generation from such samples and from fresh tumour and, critically, with
other participant groups develop new statistical / bioinformatic
approaches to data analysis.
In this first - of - a-kind survey, researchers used a forward - looking
approach to screen the genes that produce tyrosine kinases — reasoning that somewhere in this
genomic landscape they might encounter novel mutations that spur colon cancer and
other types of cancer.
And through
approaches that allow the characterization of the entire proteome, researchers are integrating
genomic analysis with the analysis of the proteins in tumor cells to learn, in detail, how cancer - associated mutant proteins affect
other proteins.
Here, we discuss and illustrate the strengths and weaknesses of
approaches for the annotation and classification of important elements of protein - coding genes,
other genomic elements such as pseudogenes and the non-coding genome, comparative -
genomic approaches for inferring gene function, and new technologies for aiding genome annotation, as a practical guide for clinicians when considering pathogenic sequence variation.